During this unprecedented time, the AHPBA recognizes the challenge that COVID-19 presents to health care providers and our patients and the importance of this next phase of surgical management in the COVID era. After initially suspending all elective surgeries, the American College of Surgeons, and numerous other public health experts have now recommended that elective surgeries resume in areas with appropriate resources. As per the American College of Surgeons, the keys to successful reintroduction of elective surgery include COVID-19 awareness and preparedness. Given that many/most hepato-pancreatic-biliary malignancies tend to be aggressive in nature, HPB surgeries have continued throughout this pandemic, albeit at a lower rate. As the operative volume begins to ramp up, continuous reassessment of local and regional factors along with COVID-19 awareness and preparedness remain essential for a safe and successful environment for all healthcare providers and patients. For more information see the Joint Statement from the ACS, ASA, AORN and AHA on Resuming Elective Surgery after COVID-19 Pandemic
